Nuria E. Campillo

4.5k total citations
137 papers, 3.5k citations indexed

About

Nuria E. Campillo is a scholar working on Molecular Biology, Pharmacology and Organic Chemistry. According to data from OpenAlex, Nuria E. Campillo has authored 137 papers receiving a total of 3.5k indexed citations (citations by other indexed papers that have themselves been cited), including 50 papers in Molecular Biology, 49 papers in Pharmacology and 37 papers in Organic Chemistry. Recurrent topics in Nuria E. Campillo's work include Computational Drug Discovery Methods (22 papers), Antibiotics Pharmacokinetics and Efficacy (21 papers) and Cholinesterase and Neurodegenerative Diseases (20 papers). Nuria E. Campillo is often cited by papers focused on Computational Drug Discovery Methods (22 papers), Antibiotics Pharmacokinetics and Efficacy (21 papers) and Cholinesterase and Neurodegenerative Diseases (20 papers). Nuria E. Campillo collaborates with scholars based in Spain, United Kingdom and United States. Nuria E. Campillo's co-authors include Juan A. Páez, Ana Martı́nez, Carmen Gil, Concepción Pérez, Carlos Roca, Daniel I. Pérez, Santiago Grau, Sònia Luque, Juan Pablo Horcajada and Víctor Sebastián-Pérez and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Journal of Biological Chemistry and Journal of Molecular Biology.

In The Last Decade

Nuria E. Campillo

130 papers receiving 3.4k citations

Author Peers

Peers are selected by citation overlap in the author's most active subfields. citations · hero ref

Author Last Decade Papers Cites
Nuria E. Campillo 1.3k 1.1k 765 674 542 137 3.5k
Simone Brogi 1.4k 1.0× 576 0.5× 724 0.9× 566 0.8× 216 0.4× 130 3.1k
Michael A. Walters 2.2k 1.6× 564 0.5× 1.1k 1.4× 633 0.9× 435 0.8× 98 5.0k
Sandra Gemma 1.4k 1.1× 723 0.6× 1.3k 1.7× 656 1.0× 257 0.5× 132 3.4k
Judith M. Rollinger 2.8k 2.1× 1.3k 1.2× 776 1.0× 772 1.1× 472 0.9× 157 6.5k
Xu Shen 2.0k 1.5× 538 0.5× 616 0.8× 778 1.2× 368 0.7× 163 4.9k
G. Madhavi Sastry 3.1k 2.3× 621 0.5× 1.1k 1.4× 1.6k 2.4× 219 0.4× 27 5.3k
Diogo Santos‐Martins 2.7k 2.0× 474 0.4× 1.0k 1.3× 1.1k 1.6× 201 0.4× 30 5.0k
Larry Walker 2.8k 2.1× 1.5k 1.3× 1.1k 1.4× 229 0.3× 449 0.8× 233 7.2k
Benoît Déprez 2.1k 1.5× 296 0.3× 1.2k 1.6× 319 0.5× 549 1.0× 134 4.1k
Luciana Scotti 1.3k 1.0× 554 0.5× 998 1.3× 645 1.0× 332 0.6× 283 3.8k

Countries citing papers authored by Nuria E. Campillo

Since Specialization
Citations

This map shows the geographic impact of Nuria E. Campillo's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Nuria E. Campillo with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Nuria E. Campillo more than expected).

Fields of papers citing papers by Nuria E. Campillo

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Nuria E. Campillo. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Nuria E. Campillo. The network helps show where Nuria E. Campillo may publish in the future.

Co-authorship network of co-authors of Nuria E. Campillo

This figure shows the co-authorship network connecting the top 25 collaborators of Nuria E. Campillo. A scholar is included among the top collaborators of Nuria E. Campillo based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Nuria E. Campillo. Nuria E. Campillo is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Ulzurrun, Eugenia, et al.. (2025). AI-Driven De Novo Design and Development of Nontoxic DYRK1A Inhibitors. Journal of Medicinal Chemistry. 68(10). 10346–10364. 1 indexed citations
2.
Ulzurrun, Eugenia, Eulalia Rodrı́guez-Martı́n, Javier García‐Nafría, et al.. (2025). FDA Drug Repurposing Uncovers Modulators of Dopamine D 2 Receptor Localization via Disruption of the NCS-1 Interaction. Journal of Medicinal Chemistry. 68(22). 23993–24010.
3.
Ponzoni, Ignacio, et al.. (2023). Explainable artificial intelligence: A taxonomy and guidelines for its application to drug discovery. Wiley Interdisciplinary Reviews Computational Molecular Science. 13(6). 22 indexed citations
4.
Ulzurrun, Eugenia, et al.. (2023). Scipion-Chem: An Open Platform for Virtual Drug Screening. Journal of Chemical Information and Modeling. 63(24). 7873–7885. 1 indexed citations
5.
Martínez, María Jimena, Axel J. Soto, Ramón Goméz Arrayás, et al.. (2023). Design of New Dispersants Using Machine Learning and Visual Analytics. Polymers. 15(5). 1324–1324. 4 indexed citations
6.
Montero, M., Carla López-Causapé, Inmaculada López-Montesinos, et al.. (2022). Comparison of Ceftolozane/Tazobactam Infusion Regimens in a Hollow-Fiber Infection Model against Extensively Drug-Resistant Pseudomonas aeruginosa Isolates. Microbiology Spectrum. 10(3). e0089222–e0089222. 7 indexed citations
7.
Martínez, María Jimena, Axel J. Soto, Carlos Roca, et al.. (2022). Multitask Deep Neural Networks for Ames Mutagenicity Prediction. Journal of Chemical Information and Modeling. 62(24). 6342–6351. 11 indexed citations
8.
Barbosa, Elizabeth, Edgar E. Lara‐Ramírez, Alma D. Paz-González, et al.. (2021). Virtual Screening of FDA-Approved Drugs against Triose Phosphate Isomerase from Entamoeba histolytica and Giardia lamblia Identifies Inhibitors of Their Trophozoite Growth Phase. International Journal of Molecular Sciences. 22(11). 5943–5943. 17 indexed citations
9.
Luque, Sònia, William Hope, Luisa Sorlí, et al.. (2021). Dosage Individualization of Linezolid: Precision Dosing of Linezolid To Optimize Efficacy and Minimize Toxicity. Antimicrobial Agents and Chemotherapy. 65(6). 14 indexed citations
10.
11.
Roca, Carlos, et al.. (2021). AI in drug development: a multidisciplinary perspective. Molecular Diversity. 25(3). 1461–1479. 38 indexed citations
12.
Schroeder, Michael, Sebastian Salentin, V. Joachim Haupt, et al.. (2020). Computational Drug Repositioning for Chagas Disease Using Protein-Ligand Interaction Profiling. International Journal of Molecular Sciences. 21(12). 4270–4270. 26 indexed citations
13.
Jiménez, Mercedes, Nuria E. Campillo, & Matilde Cañelles. (2020). COVID-19 Vaccine Race: Analysis of Age-Dependent Immune Responses against SARS-CoV-2 Indicates that more than Just One Strategy May Be Needed. Current Medicinal Chemistry. 28(20). 3964–3979. 11 indexed citations
14.
15.
Luque, Sònia, William Hope, Nuria E. Campillo, et al.. (2019). Population Pharmacokinetics of Anidulafungin in Critically Ill Patients. Antimicrobial Agents and Chemotherapy. 63(7). 14 indexed citations
16.
Sorlí, Luisa, Sònia Luque, Jian Li, et al.. (2019). Colistin Use in Patients with Chronic Kidney Disease: Are We Underdosing Patients?. Molecules. 24(3). 530–530. 8 indexed citations
17.
Andrade, Peterson de, Carlos Roca, Concepción Pérez, et al.. (2018). Highly potent and selective aryl-1,2,3-triazolyl benzylpiperidine inhibitors toward butyrylcholinesterase in Alzheimer's disease. Bioorganic & Medicinal Chemistry. 27(6). 931–943. 37 indexed citations
18.
Sorlí, Luisa, Sònia Luque, Concepción Segura, et al.. (2017). Impact of colistin plasma levels on the clinical outcome of patients with infections caused by extremely drug-resistant Pseudomonas aeruginosa. BMC Infectious Diseases. 17(1). 11–11. 34 indexed citations
19.
Caballero‐Velázquez, Teresa, Luis Ignacio Sánchez‐Abarca, Estefanía García‐Guerrero, et al.. (2016). Cannabinoid derivatives exert a potent anti-myeloma activity bothin vitroandin vivo. International Journal of Cancer. 140(3). 674–685. 32 indexed citations
20.
Luque, Sònia, Santiago Grau, Francisco Álvarez-Lerma, et al.. (2014). Plasma and cerebrospinal fluid concentrations of linezolid in neurosurgical critically ill patients with proven or suspected central nervous system infections. International Journal of Antimicrobial Agents. 44(5). 409–415. 51 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Simone Brogi Breakdown of academic impact, for papers by Michael A. Walters Breakdown of academic impact, for papers by Sandra Gemma Breakdown of academic impact, for papers by Judith M. Rollinger Breakdown of academic impact, for papers by Xu Shen Breakdown of academic impact, for papers by G. Madhavi Sastry Breakdown of academic impact, for papers by Diogo Santos‐Martins Breakdown of academic impact, for papers by Larry Walker Breakdown of academic impact, for papers by Benoît Déprez Breakdown of academic impact, for papers by Luciana Scotti
Rankless by CCL
2026